KPIs & Operating Metrics(New)

Balance Sheet

Accounts Payables Accumulated Expenses Assets Buildings Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Construction in Progress Curent Deferred Tax Liability Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Current Taxes Finished Goods Goodwill Goodwill & Intangibles Intangibles Inventory Land & Improvements Liabilities and Shareholders Equity Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Pension Prepaid Assets Property, Plant & Equipment (Net)Raw Materials Receivables Receivables - Net Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares Work In Process

Daily Values

Growth Metrics

Others

Charles River Laboratories International (CRL) Receivables - Other (2016 - 2022)

Historic Receivables - Other for Charles River Laboratories International (CRL) over the last 10 years, with Q3 2022 value amounting to $7.7 million.

Charles River Laboratories International's Receivables - Other changed N/A to $7.7 million in Q3 2022 from the same period last year, while for Sep 2022 it was $7.7 million, marking a year-over-year change of. This contributed to the annual value of $7.5 million for FY2021, which is N/A changed from last year.
As of Q3 2022, Charles River Laboratories International's Receivables - Other stood at $7.7 million.
Charles River Laboratories International's Receivables - Other's 5-year high stood at $9.0 million during Q1 2022, with a 5-year trough of $7.5 million in Q4 2021.